{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:31:44Z","timestamp":1791207104214,"version":"4.1.0"},"reference-count":66,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,10]],"date-time":"2018-11-10T00:00:00Z","timestamp":1541808000000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["U19 MH069056"],"award-info":[{"award-number":["U19 MH069056"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["K23 MH086690"],"award-info":[{"award-number":["K23 MH086690"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006379","name":"Veterans Affairs Clinical Science Research and Development","doi-asserted-by":"publisher","award":["09S-NIMH-002"],"award-info":[{"award-number":["09S-NIMH-002"]}],"id":[{"id":"10.13039\/100006379","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009427","name":"Acadia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009427","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Assurex"},{"name":"Axsome"},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Janssen"},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Otsuka"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Takeda"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Community"},{"DOI":"10.13039\/501100003107","name":"German Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"B\u00f6hringer-Ingelheim Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alkermes"},{"DOI":"10.13039\/100004325","name":"Astra Zeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015428","name":"Brainsway","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100015428","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Euthymics"},{"name":"Neosync"},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Shire"},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001192","name":"Johnson Family Chair","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001192","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008894","name":"Stryker","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008894","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"Wounded Warrior Project, Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"NIMH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000345","name":"McCormick Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007123","name":"Stanley Medical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007123","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","biologicalpsychiatryjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.biopsych.2017.06.024","type":"journal-article","created":{"date-parts":[[2017,7,4]],"date-time":"2017-07-04T02:15:42Z","timestamp":1499134542000},"page":"866-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress Disorder"],"prefix":"10.1016","volume":"82","author":[{"given":"Boadie W.","family":"Dunlop","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth B.","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Iosifescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay J.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas C.","family":"Neylan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julius C.","family":"Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Carrillo-Roa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becky","family":"Kinkead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara O.","family":"Rothbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles B.","family":"Nemeroff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen S.","family":"Mayberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2017.06.024_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1682\/JRRD.2011.09.0162","article-title":"Assessment of posttraumatic stress disorder-related functional impairment: A review","volume":"49","author":"Rodriguez","year":"2012","journal-title":"J\u00a0Rehabil Res Dev"},{"key":"10.1016\/j.biopsych.2017.06.024_bib2","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1176\/appi.ajp.2007.07030504","article-title":"Functional neuroimaging of anxiety: A meta-analysis of emotional processing in PTSD, social anxiety disorder, and specific phobia","volume":"164","author":"Etkin","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/da.20292","article-title":"Noradrenergic dysfunction and the psychopharmacology of posttraumatic stress disorder","volume":"25","author":"Strawn","year":"2008","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopsych.2017.06.024_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-6632.2009.04979.x","article-title":"Status of glucocorticoid alterations in post-traumatic stress disorder","volume":"1179","author":"Yehuda","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.biopsych.2017.06.024_bib5","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.biopsych.2016.03.2108","article-title":"Higher pretreatment blood pressure is associated with greater posttraumatic stress disorder symptom reduction in soldiers treated with prazosin","volume":"80","author":"Raskind","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib6","first-page":"CD002795","article-title":"Pharmacotherapy for posttraumatic stress disorder (PTSD)","volume":"1","author":"Stein","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.biopsych.2017.06.024_bib7","series-title":"Neurobiology of PTSD","first-page":"220","article-title":"Neurobiological pathways involved in fear, stress and PTSD","author":"Heim","year":"2016"},{"key":"10.1016\/j.biopsych.2017.06.024_bib8","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1043-2760(02)00670-7","article-title":"Functional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonists","volume":"13","author":"Grammatopoulos","year":"2002","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2017.06.024_bib9","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1176\/ajp.154.5.624","article-title":"Elevated CSF corticotropin releasing factor concentrations in posttraumatic stress disorder","volume":"154","author":"Bremner","year":"1997","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1176\/ajp.156.4.585","article-title":"Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder","volume":"156","author":"Baker","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib11","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/S0006-3223(03)00571-7","article-title":"Corticotropin-releasing factor in posttraumatic stress disorder (PTSD) with secondary psychotic symptoms, nonpsychotic PTSD, and healthy control subjects","volume":"54","author":"Sautter","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib12","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.4088\/JCP.09m05106blu","article-title":"Corticotropin-releasing factor, interleukin-6, brain-derived neurotrophic factor, insulin-like growth factor-1, and substance P in the cerebrospinal fluid of civilians with posttraumatic stress disorder before and after treatment with paroxetine","volume":"72","author":"Bonne","year":"2011","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0006-3223(99)00170-5","article-title":"Corticotropin-releasing hormone receptor subtypes and emotion","volume":"46","author":"Steckler","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib14","doi-asserted-by":"crossref","first-page":"12004","DOI":"10.1073\/pnas.0803216105","article-title":"Central amygdala glucocorticoid receptor action promotes fear-associated CRH activation and conditioning","volume":"105","author":"Kolber","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.biopsych.2017.06.024_bib15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/bs2020135","article-title":"Behavioral studies and genetic alterations in CRH neurocircuitry: Insights into human psychiatric disorders","volume":"12","author":"Laryea","year":"2012","journal-title":"Behav Sci"},{"key":"10.1016\/j.biopsych.2017.06.024_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0079-6123(08)62132-9","article-title":"Long-term behavioral and neuroendocrine adaptations to adverse early experience","volume":"122","author":"Ladd","year":"2000","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.biopsych.2017.06.024_bib17","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/sj.npp.1300769","article-title":"Long-term consequences of neonatal rearing on central corticotropin-releasing factor systems in adult male rat offspring","volume":"30","author":"Plotsky","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2017.06.024_bib18","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.pharmthera.2010.08.011","article-title":"Therapeutic utility of non-peptidic CRF1 receptor antagonists in anxiety, depression, and stress-related disorders: Evidence from animal models","volume":"128","author":"Kehne","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2017.06.024_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0022-3956(00)00016-9","article-title":"Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated","volume":"34","author":"Zobel","year":"2000","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.biopsych.2017.06.024_bib20","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1177\/0269881111400650","article-title":"Preliminary evidence of anxiolytic effects of the CRF(1) receptor antagonist R317573 in the 7.5% CO(2) proof-of-concept experimental model of human anxiety","volume":"25","author":"Bailey","year":"2011","journal-title":"J\u00a0Psychopharmacol"},{"key":"10.1016\/j.biopsych.2017.06.024_bib21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nrd3702","article-title":"Neuropeptide receptor ligands as drugs for psychiatric diseases: The end of the beginning?","volume":"11","author":"Griebel","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.biopsych.2017.06.024_bib22","doi-asserted-by":"crossref","first-page":"7370","DOI":"10.1021\/jm800744m","article-title":"Synthesis and pharmacological characterization of novel drug like corticotropin-releasing factor 1 antagonists","volume":"51","author":"Fabio","year":"2008","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.biopsych.2017.06.024_bib23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/1745-6215-15-240","article-title":"Evaluation of a corticotropin releasing hormone type 1 receptor antagonist in women with posttraumatic stress disorder: Study protocol for a randomized controlled trial","volume":"15","author":"Dunlop","year":"2014","journal-title":"Trials"},{"key":"10.1016\/j.biopsych.2017.06.024_bib24","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders-Patient. SCID-I\/P, 20th edition","author":"First","year":"1995"},{"key":"10.1016\/j.biopsych.2017.06.024_bib25","first-page":"395","article-title":"Reliability and validity of a brief instrument for assessing posttraumatic stress disorder","volume":"5","author":"Foa","year":"1993","journal-title":"J\u00a0Trauma Stress"},{"key":"10.1016\/j.biopsych.2017.06.024_bib26","first-page":"75","article-title":"The development of a clinician-administered PTSD scale","volume":"8","author":"Blake","year":"1995","journal-title":"J\u00a0Trauma Stress"},{"key":"10.1016\/j.biopsych.2017.06.024_bib27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1037\/1040-3590.9.4.445","article-title":"The validation of a self-report measure of post-traumatic stress disorder: The Posttraumatic Diagnostic Scale","volume":"9","author":"Foa","year":"1997","journal-title":"Psychol Assess"},{"key":"10.1016\/j.biopsych.2017.06.024_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0145-2134(02)00541-0","article-title":"Development and validation of a brief screening version of the Childhood Trauma Questionnaire","volume":"27","author":"Bernstein","year":"2003","journal-title":"Child Abuse Neglect"},{"key":"10.1016\/j.biopsych.2017.06.024_bib29","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A\u00a0new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib30","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1192\/bjp.bp.106.032532","article-title":"Development and reliability of the SIGMA: A structured interview guide for the Montgomery\u2013\u00c5sberg Depression Rating Scale (MADRS)","volume":"192","author":"Williams","year":"2008","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib31","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0006-3223(02)01866-8","article-title":"The 16-item Quick Inventory of Depressive Symptomatology (QIDS), Clinician-Rating (QIDS-C), and Self-Report (QIDS-SR): A psychometric evaluation in patients with major depression","volume":"54","author":"Rush","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib32","series-title":"Clinical global impressions. In: Early Clinical Drug Evaluation Assessment Manual for Psychopharmacology, Revised","first-page":"217","author":"Guy","year":"1976"},{"key":"10.1016\/j.biopsych.2017.06.024_bib33","series-title":"Handbook of Psychiatric Measures","first-page":"13","article-title":"Sheehan disability scale","author":"Sheehan","year":"2000"},{"key":"10.1016\/j.biopsych.2017.06.024_bib34","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1176\/ajp.2007.164.7.1035","article-title":"Columbia classification algorithm of suicide assessment (C-CASA): Classification of suicidal events in the FDA\u2019s pediatric suicidal risk analysis of antidepressants","volume":"164","author":"Posner","year":"2007","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/00131746-200603000-00002","article-title":"Self-rated global measure of the frequency, intensity and burden of side effects","volume":"12","author":"Wisniewski","year":"2006","journal-title":"J\u00a0Psychiatr Pract"},{"key":"10.1016\/j.biopsych.2017.06.024_bib36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/archgenpsychiatry.2007.26","article-title":"Influence of child abuse on adult depression: Moderation by the corticotropin-releasing hormone receptor gene","volume":"65","author":"Bradley","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib37","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/jama.283.14.1837","article-title":"Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial","volume":"283","author":"Brady","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2017.06.024_bib38","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1001\/archpsyc.58.5.485","article-title":"Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder","volume":"58","author":"Davidson","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib39","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1176\/appi.ajp.158.12.1982","article-title":"Efficacy and safety of paroxetine treatment for chronic PTSD: A fixed-dose, placebo-controlled study","volume":"158","author":"Marshall","year":"2001","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4088\/JCP.v62n1105","article-title":"Paroxetine in the treatment of chronic posttraumatic stress disorder: Results of a placebo-controlled, flexible-dosage trial","volume":"62","author":"Tucker","year":"2001","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib41","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1001\/archpsyc.63.10.1158","article-title":"Treatment of posttraumatic stress disorder with venlafaxine extended release: A 6-month randomized controlled trial","volume":"63","author":"Davidson","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0006-8993(99)01912-5","article-title":"Behavioral response to stress are intact in CRF-deficient mice","volume":"845","author":"Dunn","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2017.06.024_bib43","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1523\/JNEUROSCI.5531-03.2004","article-title":"Corticotropin-releasing factor and Urocortin 1 modulate excitatory glutamatergic synaptic transmission","volume":"24","author":"Liu","year":"2004","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.biopsych.2017.06.024_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0006-8993(92)90459-M","article-title":"The antidepressants fluoxetine, idazoxan and phenelzine alter corticotropin-releasing-hormone and tyrosine hydroxylase mRNA levels in rat brain: Therapeutic implications","volume":"572","author":"Brady","year":"1992","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2017.06.024_bib45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0304-3940(99)00295-5","article-title":"Chronic treatment with the antidepressant amitriptyline decreases CRF-R1 receptor mRNA levels in the rat amygdala","volume":"266","author":"Aubry","year":"1999","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2017.06.024_bib46","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1124\/jpet.300.3.1085","article-title":"Regulation of corticotropin-releasing factor neuronal systems and hypothalamic-pituitary-adrenal axis activity by stress and chronic antidepressant treatment","volume":"300","author":"Stout","year":"2002","journal-title":"J\u00a0Pharm Exp Therapeutics"},{"key":"10.1016\/j.biopsych.2017.06.024_bib47","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.psyneuen.2007.12.012","article-title":"Effects of trauma-related audiovisual stimulation on cerebrospinal fluid norepinephrine and corticotropin-releasing hormone concentrations in post-traumatic stress disorder","volume":"33","author":"Geracioti","year":"2008","journal-title":"Psychoneuroendocrinol"},{"key":"10.1016\/j.biopsych.2017.06.024_bib48","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0006-3223(99)00224-3","article-title":"The impact of early adverse experiences on brain systems involved in the pathophysiology of anxiety and affective disorders","volume":"46","author":"Heim","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib49","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/(SICI)1098-2396(19990915)33:4<304::AID-SYN7>3.0.CO;2-Z","article-title":"Discrete local application of corticotropin-releasing factor increases locus coeruleus discharge and extracellular norepinephrine in rat hippocampus","volume":"33","author":"Page","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.biopsych.2017.06.024_bib50","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0014-2999(99)00793-1","article-title":"The role of afferents to the locus coeruleus in the handling stress-induced increase in the release of noradrenaline in the medial prefrontal cortex: A dual-probe microdialysis study in the rat brain","volume":"387","author":"Kawahara","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2017.06.024_bib51","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0893-133X(99)00093-7","article-title":"Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus","volume":"22","author":"Kirby","year":"2000","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2017.06.024_bib52","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nn.2529","article-title":"CRF receptor 1 regulates anxiety behavior via sensitization of 5HT2 receptor signaling","volume":"5","author":"Magalhaes","year":"2010","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.biopsych.2017.06.024_bib53","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1126\/science.1202107","article-title":"Glutamatergic and dopaminergic neurons mediate anxiogenic and anxiolytic effects of CRHR1","volume":"333","author":"Refojo","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2017.06.024_bib54","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.biopsych.2013.10.013","article-title":"Sex differences in corticotropin-releasing factor receptor-1 action within the dorsal raphe nucleus in stress responsivity","volume":"75","author":"Howerton","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib55","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/npp.2014.316","article-title":"The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle","volume":"40","author":"Grillon","year":"2015","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2017.06.024_bib56","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.pnpbp.2009.06.022","article-title":"Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxiety-like versus phasic fear-like responses","volume":"33","author":"Walker","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2017.06.024_bib57","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1101\/lm.031799.113","article-title":"Neuronal correlates of fear conditioning in the bed nucleus of the stria terminalis","volume":"20","author":"Haufler","year":"2013","journal-title":"Learn Mem"},{"key":"10.1016\/j.biopsych.2017.06.024_bib58","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1017\/S1461145709990496","article-title":"CRF receptor blockade prevents initiation and consolidation of stress effects on affect in the predator stress model of PTSD","volume":"13","author":"Adamec","year":"2010","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2017.06.024_bib59","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1038\/npp.2013.336","article-title":"Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult mice","volume":"39","author":"Toth","year":"2014","journal-title":"Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2017.06.024_bib60","unstructured":"GlaxoSmithKline (2014): Results summary for CRS106139. A six-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study evaluating the efficacy, safety, and tolerability of GSK561679 compared to placebo in female subjects, diagnosed with major depressive disorder. Available at: http:\/\/download.gsk-clinicalstudyregister.com\/files\/ee490a01-8433-4cba-a027-9c486b866a67. Accessed January 12,\u00a02017."},{"key":"10.1016\/j.biopsych.2017.06.024_bib61","unstructured":"GlaxoSmithKline (2013): Protocol summary for CRH108571. Double-blind, randomized, placebo and Alprazolam-controlled three-period crossover incomplete block design study to compare putative anxiolytic-like fRMI activity of GW876008 and GSK561679 after single-dose administration in subjects with Social Anxiety Disorder (SAD). Available at: https:\/\/www.gsk-clinicalstudyregister.com\/study\/CRH108571?search=study&#ps. Accessed January 12,\u00a02017."},{"key":"10.1016\/j.biopsych.2017.06.024_bib62","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0196-9781(01)00387-4","article-title":"Mouse models of altered CRH-binding protein expression","volume":"22","author":"Seasholtz","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/j.biopsych.2017.06.024_bib63","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1017\/S1461145710001409","article-title":"Corticotropin-releasing factor and noradrenergic signaling exert reciprocal control over startle reactivity","volume":"14","author":"Gresack","year":"2011","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2017.06.024_bib64","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/da.22176","article-title":"Corticotropin releasing hormone receptor 2 (CRHR-2) gene is associated with decreased risk and severity of posttraumatic stress disorder in women","volume":"30","author":"Wolf","year":"2013","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.biopsych.2017.06.024_bib65","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/74263","article-title":"Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behavior and are hypersensitive to stress","volume":"25","author":"Bale","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.biopsych.2017.06.024_bib66","doi-asserted-by":"crossref","first-page":"5295","DOI":"10.1523\/JNEUROSCI.23-12-05295.2003","article-title":"Increased depression-like behaviors in corticotropin-releasing factor receptor-2-deficient mice: Sexually dichotomous responses","volume":"23","author":"Bale","year":"2002","journal-title":"J\u00a0Neurosci"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322317317298?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322317317298?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T23:25:20Z","timestamp":1716333920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322317317298"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":66,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0006322317317298"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2017.06.024","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corticotropin-Releasing Factor Receptor 1 Antagonism Is Ineffective for Women With Posttraumatic Stress Disorder","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2017.06.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}